Apple has been granted De Novo classification by the FDA for the Apple Watch Series 4. This certification as a unique device allows Apple Watch customers running watchOS 5.1.2 access to features that enable the detection of irregular heart rhythms. Consumers will be notified when the PPG-enabled...